Cargando…

The feasibility of Gazefinder under 12 months of age infants

Eye-tracking to evaluate gaze patterns has developed as an assessment tool for children with autism spectrum disorder (ASD). Gazefinder is one of Eye-tracking devices and few studies have investigated whether it can measure the gaze data of infants under 12 months of age. We conducted a prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Shuntaro, Takahashi, Tomoo, Tsukamoto, Kazuki, Matsumura, Misaki, Takigawa, Ryo, Sakai, Yasuo, Maniwa, Sokichi, Murphy, Lynne, Taketani, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113266/
https://www.ncbi.nlm.nih.gov/pubmed/33976346
http://dx.doi.org/10.1038/s41598-021-89585-7
_version_ 1783690824527118336
author Fukushima, Shuntaro
Takahashi, Tomoo
Tsukamoto, Kazuki
Matsumura, Misaki
Takigawa, Ryo
Sakai, Yasuo
Maniwa, Sokichi
Murphy, Lynne
Taketani, Takeshi
author_facet Fukushima, Shuntaro
Takahashi, Tomoo
Tsukamoto, Kazuki
Matsumura, Misaki
Takigawa, Ryo
Sakai, Yasuo
Maniwa, Sokichi
Murphy, Lynne
Taketani, Takeshi
author_sort Fukushima, Shuntaro
collection PubMed
description Eye-tracking to evaluate gaze patterns has developed as an assessment tool for children with autism spectrum disorder (ASD). Gazefinder is one of Eye-tracking devices and few studies have investigated whether it can measure the gaze data of infants under 12 months of age. We conducted a prospective cross-sectional study from April 2019 to March 2020 in a periodic health checkup in Ohchi County, Shimane, Japan. Participants included infants between 4 and 11 months of age who were not suspected the presence of developmental problems. Ninety-three participants’ datapoints were analyzed. The mean age was 6.5 months and mean developmental quotient was 88%. The mean fixation time percentage of all sequences was 81.0% (standard deviation; 4.4), and there was no significant difference in each age group. Infants in all groups showed a significantly higher predilection for eyes than for mouths. There was a positive association of age with human gaze and a negative association with geometric gaze. Moreover, we confirmed that joint attention skills were enhanced in accordance with their growth process. The eye-tracking data were almost corresponding to previous studies’ data of infant with typical development and Gazefinder could be applied to infants starting at 4 months of age.
format Online
Article
Text
id pubmed-8113266
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81132662021-05-12 The feasibility of Gazefinder under 12 months of age infants Fukushima, Shuntaro Takahashi, Tomoo Tsukamoto, Kazuki Matsumura, Misaki Takigawa, Ryo Sakai, Yasuo Maniwa, Sokichi Murphy, Lynne Taketani, Takeshi Sci Rep Article Eye-tracking to evaluate gaze patterns has developed as an assessment tool for children with autism spectrum disorder (ASD). Gazefinder is one of Eye-tracking devices and few studies have investigated whether it can measure the gaze data of infants under 12 months of age. We conducted a prospective cross-sectional study from April 2019 to March 2020 in a periodic health checkup in Ohchi County, Shimane, Japan. Participants included infants between 4 and 11 months of age who were not suspected the presence of developmental problems. Ninety-three participants’ datapoints were analyzed. The mean age was 6.5 months and mean developmental quotient was 88%. The mean fixation time percentage of all sequences was 81.0% (standard deviation; 4.4), and there was no significant difference in each age group. Infants in all groups showed a significantly higher predilection for eyes than for mouths. There was a positive association of age with human gaze and a negative association with geometric gaze. Moreover, we confirmed that joint attention skills were enhanced in accordance with their growth process. The eye-tracking data were almost corresponding to previous studies’ data of infant with typical development and Gazefinder could be applied to infants starting at 4 months of age. Nature Publishing Group UK 2021-05-11 /pmc/articles/PMC8113266/ /pubmed/33976346 http://dx.doi.org/10.1038/s41598-021-89585-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Fukushima, Shuntaro
Takahashi, Tomoo
Tsukamoto, Kazuki
Matsumura, Misaki
Takigawa, Ryo
Sakai, Yasuo
Maniwa, Sokichi
Murphy, Lynne
Taketani, Takeshi
The feasibility of Gazefinder under 12 months of age infants
title The feasibility of Gazefinder under 12 months of age infants
title_full The feasibility of Gazefinder under 12 months of age infants
title_fullStr The feasibility of Gazefinder under 12 months of age infants
title_full_unstemmed The feasibility of Gazefinder under 12 months of age infants
title_short The feasibility of Gazefinder under 12 months of age infants
title_sort feasibility of gazefinder under 12 months of age infants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113266/
https://www.ncbi.nlm.nih.gov/pubmed/33976346
http://dx.doi.org/10.1038/s41598-021-89585-7
work_keys_str_mv AT fukushimashuntaro thefeasibilityofgazefinderunder12monthsofageinfants
AT takahashitomoo thefeasibilityofgazefinderunder12monthsofageinfants
AT tsukamotokazuki thefeasibilityofgazefinderunder12monthsofageinfants
AT matsumuramisaki thefeasibilityofgazefinderunder12monthsofageinfants
AT takigawaryo thefeasibilityofgazefinderunder12monthsofageinfants
AT sakaiyasuo thefeasibilityofgazefinderunder12monthsofageinfants
AT maniwasokichi thefeasibilityofgazefinderunder12monthsofageinfants
AT murphylynne thefeasibilityofgazefinderunder12monthsofageinfants
AT taketanitakeshi thefeasibilityofgazefinderunder12monthsofageinfants
AT fukushimashuntaro feasibilityofgazefinderunder12monthsofageinfants
AT takahashitomoo feasibilityofgazefinderunder12monthsofageinfants
AT tsukamotokazuki feasibilityofgazefinderunder12monthsofageinfants
AT matsumuramisaki feasibilityofgazefinderunder12monthsofageinfants
AT takigawaryo feasibilityofgazefinderunder12monthsofageinfants
AT sakaiyasuo feasibilityofgazefinderunder12monthsofageinfants
AT maniwasokichi feasibilityofgazefinderunder12monthsofageinfants
AT murphylynne feasibilityofgazefinderunder12monthsofageinfants
AT taketanitakeshi feasibilityofgazefinderunder12monthsofageinfants